Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Haleon (HLN)

Price 397.10p on 17-09-2024 at 15:27:26
Change 3.10p 0.79%
Buy 397.20p
Sell 397.10p
Buy / Sell HLN Shares
Last Trade: Sell 1,094.00 at 397.10p
Day's Volume: 6,206,167
Last Close: 394.00p
Open: 396.60p
ISIN: GB00BMX86B70
Day's Range 394.70p - 397.90p
52wk Range: 310.45p - 397.90p
Market Capitalisation: £36,173m
VWAP: 396.26873p
Shares in Issue: 9,109m

Recent Trades History Haleon (HLN)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,094 397.10p Automatic Execution
15:27:25 - 17-Sep-24
Buy* 529 397.10p Automatic Execution
15:27:25 - 17-Sep-24
Buy* 1,100 397.10p Automatic Execution
15:27:25 - 17-Sep-24
Buy* 526 397.10p Automatic Execution
15:27:19 - 17-Sep-24
Buy* 1,931 397.10p Automatic Execution
15:27:19 - 17-Sep-24
Buy* 1,436 397.10p Automatic Execution
15:27:19 - 17-Sep-24
Buy* 506 397.10p Automatic Execution
15:27:19 - 17-Sep-24
Buy* 3,885 397.10p Automatic Execution
15:27:19 - 17-Sep-24
Buy* 144 397.10p Automatic Execution
15:27:19 - 17-Sep-24
Buy* 871 397.10p Automatic Execution
15:27:19 - 17-Sep-24

Share Price History for Haleon

Time period:
to
Date Open High Low Close Volume

Share News for Haleon

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

13th Sep 2024 09:07

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

UK dividends calendar - next 7 days

12th Sep 2024 13:50

Read More

LONDON BROKER RATINGS: 3i Infrastructure cut; JPMorgan likes Rotork

11th Sep 2024 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

IN BRIEF: Futura Medical's Eroxon to be available in US from October

2nd Sep 2024 15:35

Futura Medical PLC - sexual health products company - Says Eroxon is available for pre-order online, and will also be available in US stores from October. Eroxon is a fast-acting gel used to treat erectile dysfunction, which has been available without a prescription in UK pharmacies since March last year. More recently, Futura struck a licensing deal with Haleon PLC for the gel, which has led to its availability in the US. Read More

IN BRIEF: Tate & Lyle picks former De Beers CFO to be its new CFO

13th Aug 2024 09:55

Tate & Lyle PLC - London-based sweetener and food ingredients supplier - Hires Sarah Kuijlaars to be chief financial officer and board member, starting September 16. Kuijlaars previously was CFO of diamond producer and wholesaler De Beers Group, part of miner Anglo American PLC. She also was deputy CFO at Rolls-Royce Holdings PLC and was a finance executive at Shell PLC. Kuijlaars replaces Dawn Allen, who is leaving Tate & Lyle to become CFO of consumer health products firm Haleon PLC. Read More

FTSE 100 Latest
Value8,313.03
Change34.59

Login to your account

Forgot Password?

Not Registered